±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1408  |  »Ø¸´: 11
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

waiting113

Òø³æ (ÕýʽдÊÖ)

[½»Á÷] ÇóÖú·­ÒëÒ»¶Î£¡ËÍ10¸ö½ð±Ò

A second problem with E. coli is the limited supply of complementary NADPH:cytochrome P450 reductase that is also essential for the correct function of reconstituted plant cytochrome P450 enzymes. Yeast does have endogenous microsomal cytochrome P450 enzymes and energy supporting systems, what is a major advantage for this host system.The taxadiene synthase encoding gene has also been expressed in A. thaliana. Constitutive expression of the gene led to taxadiene accumulation, but the A. thaliana plants showed growth retardation and decreased levels of photosynthetic pigment. The negative effects may have been caused by the toxicity of taxadiene, but more likely they are a result of the disturbance of the endogenous geranylgeranyldiphosphate pool. The use of an inducible expression system resulted in an increase of taxadiene accumulation. These findings clearly show that only the expression of heterologous genes result in the production of the desired compound, but the influence on the metabolic network has to be taken into account as well.Carotenoids are tetraterpenoids (C40 compounds) and produced in many plants and microorganisms. Their main biological function is the protection against oxidative damage and some are used as warning colours in plant defense system. The commercial interest for carotenoids can be explained mainly by their use as colorant, nutraceutical, or antioxidant in food and cosmetics. Next to that, it has been suggested that carotenoids could possibly play an important role as antic¬arcinogenic drug and in the prevention of chronic diseases. The carotenoid b-carotene is the primary source of Vitamin A in the human diet. The biosynthesis of carotenoids starts with the tail-to-tail coupling of two molecules of the general precursor GGDP by phytoene synthase (CrtB) resulting in the colorless carotenoid phytoene. Desaturation reactions inserting four additional double bonds in the molecule give eventually lycopene, the main carotenoid in tomato fruit, from which different cyclic and acyclic structures can be synthesized depending on the producing organism. Lycopene cyclase (CrtY) catalyses the cyclization at both ends of the lycopene molecule, resulting in two b-rings at the molecule b-carotene. Several other enzymes involved in the carotenoid biosyntheses have been identified, responsible not only for cyclization, but for glycosylation and diverse oxygenations as well.More than 600 different naturally occuring carotenoids have been identified so far. The three main carotenoids b-carotene, asthaxantin, and lycopene are produced by chemical synthesis and fermentation for commercial purposes. However, for carotenoids combinatorial biosynthesis in microorganisms is also described. Several carotenoid producing plants have been genetically modified to increase the production of the desired compounds. This review does not describe this research topic in detail, but the use of transgenic medicinal plants of Lycopersicum esculentem, Daucus carota, Solanum tuberosum, and Brassica napus has been reported. To overcome the problems with Vitamin A deficiencies in the third world, the biosynthetic pathway to b¬carotene engineered in rice (Oryza sativa) has led to the production of Golden Rice providing b-carotene, also referred to as pro-Vitamin A. Here we focus on the use of microorganisms for the production of carotenoids.The production of carotenoids by fermentation of carotenoid producing microorganisms such as Xanthophyllomyces den¬drorhous, Haematococcus pluvialis, and Blakeslea trispora has been investigated. X. dendrorhous produces 200¨C400 mg g~1 astaxanthin (85% of total carotenoid content). Engineering of X. dendrorhous by random mutagenesis led to an increase of 1.5¨C9 fold of the astaxanthin production inmutant strains. As a disadvantage of this approach growth inhibition and a decrease of biomass have been observed. More sophisticated recombinant DNA techniques introducing multi¬ple copies of genes encoding a bifunctional phytoene synthase/ lycopene cyclase and a phytoene desaturase also showed an increase in carotenoid production, but unexpectedly mostly other carotenoid structures than the desired astaxanthin (reviewed by Visser et al., 2003). Apparently, the hydroxylating enzyme became limited by overexpressing the mentioned enzymes. Several groups used gene clusters of Erwinia sp. for the expression in other hosts. In the last years several non¬carotenoid producing organisms have been explored for the production of carotenoids. This heterologous production is dependent on efficient expression systems for the carotenoid gene clusters, but increasing the supply of precursors in the host organisms is of importance as well. The yeasts Candida utilis and S. cereviseae have been engineered for the production of lycopene, b-carotene, and astaxantin. The prokaryote E. coli is most elaborated as a heterologous host, because most of the genes were already expressed in the strain for functional analysis. An overview of the heterologous expression of carotenoid gene clusters in the three mentioned non-carotenogenic hosts is described by The production of carotenoids in a host requires the biosynthesis of the intermediate GGDP. E. coli produces the C15 precursor FDP for endogenous terpenoid molecules. The extension of the prenyl chain to C20 has been performed by the expression of the CrtE gene encoding geranygeranyl dipho¬sphate synthase from Erwinia sp.. This prenyltransferase catalyses the production of GGDP from FDP. The GGDP synthase encoding gene gps from Archaeoglobus fulgidis has been expressed as well. Expression of this gene is more efficient, because the enzyme catalyses the three chain elongation reactions starting from the C5 precursors to the C20 molecule.One way to increase the heterologous production is to increase the pool of precursors in the host. Overexpression of several genes upstream in the isoprenoid biosynthesis resulted in the identification and overcome of bottlenecks in this pathway. Where the expression of a carotenoid gene cluster in C. utilis resulted in a lycopene production of 1.1 mg g~1 (dry weight) of cells, the overexpression of the catalytic domain of the HMG-CoA enzyme, involved in the isoprenoid biosynthesis via the mevalonate pathway, resulted in a 4-fold increase. Following disruption of the ergosterol biosynthetic gene ERG9 encoding squalene synthase yielded even more lycopene (7.8 mg g~1 (dry weight) of cells).To increase the isoprenoid flux in E. coli several genes of the DOXP pathway have been overexpressed. This resulted in a maximum increase of 10 times of the total carotenoid produc¬tion. Overexpression of genes encoding enzymes involved in a biosynthetic pathway is not always the solution for higher production levels, because they often cause an imbalance in the metabolic system of a host cell. Regulation of the supply of precursors and expression levels can contribute to the heterologous biosynthesis systems as well. The negative effects of overexpressing a rate limiting protein has been demonstrated for the deoxyxylulose phosphate synthase gene (dxs). The use of a multicopy plasmid containing a tac promoter resulted in a decrease of growth and lycopene production when expression was induced by IPTG where the dxs gene constructed on a low copy plasmid did not show these negative effects. Instead of plasmids the strong bacteriophage T5 promoter has been used to replace native promoters in E. coli. As a consequence the increased expression of isoprenoid genes led to improved production of lycopene (6 mg g~1 of dry cell weight) in E. coli. This production yield is comparable to the levels produced by carotenoid producing microorganims. Another approach to regulate the metabolic flux towards specific carotenoids has been observed by using a construct containing mRNA stability control elements. Varia¬tion of the mRNA stability modulated the flux of carotenoid production 300 fold towards b-carotene relative to lycopene.The balance of the starting precursors of the DOXP pathway has been investigated by Farmer and Liao. Over¬expression of several central metabolic genes redirected the flux of pyruvate towards glyceraldehyde 3-phosphate, resulting in an increase of lycopene in the heterologous E. coli strain. The same group also tried to design a controlled expression system for limiting enzymatic steps using an artificial intracellular loop.Since most carotenoid genes of different origin can function together in a host, combining several enzymatic combinations led to the production of new carotenoid structures not isolated from nature before.The use of host cells gives the opportunity to use directed evolution techniques for the modification of enzymes as well. Schmidt-Dannert et al. shuffled phytoene synthases of different bacterial species, which has resulted in a fully conjugated carotenoid containing six instead of four double bonds. The combination with shuffled lycopene synthases has shown production of the monocyclic carotenoid torulene. Extension of these pathways with other carotenoid modifying enzymes led to the production of novel structures in E. coli. Directed evolution has been used to create carotenoid-like molecules with different amounts of carbon atoms (C30, C35, C45 and C50) as well.Out of the group of terpenoids, the carotenoids have been most investigated in the production by naturally non-producing microorganisms and the production of new structures by combinatorial biosynthesis strategies. In contrast to the commercial interest, the pharmaceutical relevance of these compounds seems not to be of high importance at the moment. However, the knowledge out of this work can be applied for the heterologous production of other valuable terpenoid drugs like the mentioned artemisinin or paclitaxel. Although the avail¬ability of carotenoid gene clusters and promiscuity of the enzymes involved in the carotenoid biosynthesis are not present for structures of other terpenoids, the progress made, especially in engineering the upstream pathway creating a higher flux ofgeneral isoprenoid precursors, can be useful for all terpenoid structures as counts for the directed evolution techniques as well.

» ²ÂÄãϲ»¶

ÊÀ½çÉÏ×î³É¹¦µÄÈËÍùÍù²»ÊÇ×îÓвŻªµÄÈË£¬¶øÊÇ×îÄ͵Ãס¼ÅįµÄÈË¡£Ô½ÊǽӽüÃÎÏëµÀ·±ãÔ½¼èÐÁ£¬ÓÚÊdzɹ¦µÄÖÕµã³ÉΪһÖÖ¼á³Ö¡£
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bosimao1883

гæ (³õÈëÎÄ̳)

ÊÇÉúÎïרҵµÄѽ£¡ÂùÀ÷º¦µÄ
9Â¥2008-02-15 13:27:57
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 12 ¸ö»Ø´ð

waiting113

Òø³æ (ÕýʽдÊÖ)

Ö»ÓÐ10¼¸¸ö½ð±ÒÁË£¬Òª²»È»¾Í¶àË͵ã
ÊÀ½çÉÏ×î³É¹¦µÄÈËÍùÍù²»ÊÇ×îÓвŻªµÄÈË£¬¶øÊÇ×îÄ͵Ãס¼ÅįµÄÈË¡£Ô½ÊǽӽüÃÎÏëµÀ·±ãÔ½¼èÐÁ£¬ÓÚÊdzɹ¦µÄÖÕµã³ÉΪһÖÖ¼á³Ö¡£
2Â¥2008-02-13 11:53:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

china386

Ìú³æ (³õÈëÎÄ̳)

»Ø¸´

¡ï ¡ï ¡ï ¡ï ¡ï
hathq(½ð±Ò-5,VIP+0):ÇëÎðÕÕ°á·­ÒëÈí¼þ»òÔÚÏß·­Òë½øÐв»¸ºÔðÈεÄÓ¦Öú,¸ù¾Ý°æ¹æÎÒÃǽ«¿Û³ýÄã5½ð±Ò,ллÄã¶ÔÎÒÃǹ¤×÷µÄÀí½â
µÚ¶þ¸öÎÊÌâÓë´ó³¦¸Ë¾úÊǹ©Ó¦ÓÐÏ޵Ļ¥²¹ÐÔºÍNADPH £ºÏ¸°ûÉ«ËØP450»¹Ô­Ã¸£¬ÄÇÒ²ÊDZز»¿ÉÉÙµÄÕýÈ·¹¦ÄÜÖØ×éÖ²Îïϸ°ûÉ«ËØP450ø¡£½ÍĸÊÇ·ñÓÐÄÚÔ´ÐÔ΢Á£Ìåϸ°ûÉ«ËØP450øºÍÄÜÔ´µÄÖ§³ÅÌåϵ£¬Ê²Ã´ÊÇÒ»´óÓÅÊÆ£¬ÎªÕâÖ÷ϵͳ×ÏɼºÏø±àÂë»ùÒò£¬Ò²ÓÐÈ˱íʾ£¬ÔÚÄâÄϽ档¹¹»ùÒòµÄ±í´ï£¬µ¼ÖÂ×Ïɼ»ýÀÛ£¬µ«ÄâÄϽæÖ²Îï±íÃ÷£¬Éú³¤³Ù»º£¬²¢¼õÉÙ¸÷¼¶¹âºÏÉ«ËØ¡£¸ºÃæÐ§Ó¦¿ÉÄÜÒѾ­Ôì³ÉµÄ¶¾ÐÔ×Ïɼ£¬µ«¸ü¿ÉÄÜÊÇÒ»¸ö½á¹û£¬¸ÉÈÅÁËÄÚÔ´geranylgeranyldiphosphate³Ø¡£Ê¹ÓÃÒ»ÖÖÓÕµ¼±í´ïϵͳ£¬µ¼ÖÂÔö¼ÓÁË×Ïɼ»ýÀÛ¡£ÕâЩ½á¹ûÇå³þµØ±íÃ÷£¬Ö»Óбí´ïÍâÔ´»ùÒò£¬½á¹ûÔÚÉú²úÀíÏëµÄ¸´ºÏÐÍ£¬µ«Ó°Ï죬¶Ô´úÐ»ÍøÂç±ØÐ뿼Âǵ½×÷Ϊwell.carotenoidsÊÇtetraterpenoids £¨ c40»¯ºÏÎ £¬²¢ÖÆ×÷ÁËÐí¶àÖ²ÎïºÍ΢ÉúÎï¡£ÆäÖ÷ÒªÉúÎïѧ¹¦ÄÜÊDZ£»¤£¬·ÀÖ¹Ñõ»¯ËðÉ˵ģ¬ÓÐЩÊÇÓÃÀ´×÷ΪԤ¾¯ÑÕÉ«ÔÚÖ²Îï·ÀÓùϵͳ¡£ÉÌÒµÀûÒæÎªÀàºúÂܲ·ËØ¿ÉÒÔ½âÊÍ£¬Ö÷ÒªÊÇÀûÓÃËûÃÇ×÷Ϊ×ÅÉ«¼Á£¬ Nutraceutical¹«Ë¾£¬»ò¿¹Ñõ»¯¼Á£¬ÔÚʳƷºÍ»¯×±Æ·¡£ÅԱߣ¬ÓÐÒâ¼ûÈÏΪ£¬ÀàºúÂܲ·ËØ¿ÉÄܰçÑÝÒ»¸öÖØÒªµÄ½ÇÉ«£¬×÷ΪanticÐÐÕþ³¤¹ÙarcinogenicÒ©ÎïºÍÔ¤·ÀÂýÐÔ¼²²¡¡£ÀàºúÂܲ·ËصÄBºúÂܲ·ËصÄÖ÷ÒªÀ´Ô´ÊÇάÉúËØAÔÚÈ˵ÄÒûʳϰ¹ß¡£ºÏ³ÉÀàºúÂܲ·ËØ´Óβ²¿µ½Î²ñîºÏµÄÁ½¸ö·Ö×ÓµÄÒ»°ãǰÕ×ggdpÓÉphytoeneºÏø£¨ crtb £© £¬µ¼ÖÂÔÚÎÞÉ«ÀàºúÂܲ·ËØphytoene ¡£±¥ºÍ·´Ó¦²åÈëÔöÉè4¸öË«¼üµÄ·Ö×Ó£¬×îÖÕÈ÷¬ÇѺìËØ£¬ÀàºúÂܲ·ËØÖ÷ÒªÔÚ·¬ÇѹûʵÖУ¬´Ó²»Í¬µÄÑ­»·ºÍ·ÇÑ­»·½á¹¹£¬¿ÉÒԺϳÉÒÀÀµÓÚÉú²úµÄÓлúÌå¡£·¬ÇѺìËØ»·»¯Ã¸£¨ crty £©´ß»¯»·ÔÚÁ½¶ËµÄ·¬ÇѺìËØ·Ö×Ó£¬Ôì³ÉÁ½¼ÜBÐÍ»·ÔÚ·Ö×ÓµÄBºúÂܲ·ËØ¡£ÆäËû¼¸¸öø²ÎÓëÀàºúÂܲ·ËØbiosynthesesÒѾ­È·¶¨£¬²»½ö¸ºÔð»·£¬µ«¶ÔÓÚÌÇ»ù»¯ºÍ¶àÑù»¯oxygenations×÷Ϊwell.more³¬¹ý600¸ö²»Í¬µÄ×ÔÈ»·¢ÉúµÄÀàºúÂܲ·ËØÒѲéÃ÷ÖÁ½ñ¡£Èý¸öÖ÷ÒªµÄÀàºúÂܲ·ËصÄBºúÂܲ·ËØ£¬ asthaxantin £¬·¬ÇѺìËØÊÇÓÉ»¯Ñ§ºÏ³ÉºÍ·¢½Í×÷ÉÌÒµÓÃ;¡£È»¶ø£¬¶ÔÀàºúÂܲ·ËصÄ×éºÏÉúÎïºÏ³ÉÖеÄ΢ÉúÎïÊÇÒ²½øÐÐÁËÃèÊö¡£¼¸ÀàºúÂܲ·ËصÄÉú²ú³§·¿ÒѾ­»ùÒò¸ÄÔ죬ÒÔÔö¼ÓÉú²úËùÆÚÍûµÄ»¯ºÏÎï¡£ÕâÏî¼ìÌÖ¹¤×÷£¬²¢²»ËµÃ÷ÕâÒ»Ñо¿¿ÎÌâϸ½Ú£¬µ«Ê¹ÓÃת»ùÒòÒ©ÓÃÖ²ÎïµÄlycopersicum esculentem £¬ºúÂܲ·£¬ÂíÁåÊí£¬¸ÊÀ¶ÐÍÓͲËÒѱ¨¾¯¡£È¥¿Ë·þÀ§ÄÑ£¬ÓëάÉúËØAȱ·¦Ö¢ÔÚµÚÈýÊÀ½ç£¬ÉúÎïºÏ³É;¾¶ÏòB £¬ÄãºúÂܲ·Ëع¤³Ì£¬ÔÚË®µ¾£¨ Oryza sativa £© £¬µ¼ÖÂÉú²úµÄ»Æ½ðµ¾Ã×ÌṩµÄBºúÂܲ·ËØ£¬Ò²³ÆÎªÇ×άÉúËØAÕâÀïÎÒÃDzàÖØÓÚÀûÓÃ΢ÉúÎïÉú²úcarotenoids.theÉú²úÀàºúÂܲ·Ëصķ¢½ÍÉú²úÀàºúÂܲ·ËØÉú²úµÄ΢ÉúÎïÈçxanthophyllomycesÊéÕ«£¬Äãdrorhous £¬ÓêÉúºìÇòÔ壬ºÍÈýæß²¼À­Ã¹¾ú¾¯·½ÒÑÕ¹¿ªµ÷²é¡£Ê®dendrorhous²úÉú200-400ºÁ¿ËG 〜ΪһϺÇàËØ£¨ 85 £¥µÄ×ÜÀàºúÂܲ·Ëغ¬Á¿£© ¡£¹¤³ÌÖеÄÊ®´ódendrorhousͨ¹ýËæ»úÍ»±ä£¬µ¼ÖÂÔö¼ÓÁË1.5-9±¶µÄϺÇàËØÉú²úinmutantÖê¡£ÓÉÓÚÕâÖÖ·½·¨µÄȱµãÉú³¤ÒÖÖÆºÍ¼õÉÙÁËÉúÎïÖÊÄÜÒѱ»¹Û²ìµ½¡£¸ü¾«ÃܵÄDNAÖØ×é¼¼ÊõÒý½ø¶à£¬ÄãÖØ·ÝµÄ»ùÒò±àÂëÒ»¸öË«¹¦ÄÜphytoeneºÏø/·¬ÇѺìËØ»·»¯Ã¸ºÍphytoeneÍÑÇâøҲÔö¼Ó£¬Õâ˵Ã÷ÔÚÀàºúÂܲ·ËØÉú²ú£¬µ«Ã»Ïëµ½´ó²¿·ÖÆäËûÀàºúÂܲ·ËصĽṹ±ÈÔ¤ÏëϺÇàËØ£¨Éó²évisserµÈÈË£¬ 2003Ä꣩ ¡£ºÜÏÔÈ»£¬ hydroxylatingø³ÉΪÓÐÏ޵ģ¬ÓɹýÉÏÊöø¡£¼¸¸öС×éÀûÓûùÒò´ØµÄÈí¸¯²¡¾úÔåΪ±í´ïÔÚÆäËûÖ÷»ú¡£ÔÚ¹ýÈ¥µÄ¼¸ÄêÖÐһЩ·ÇÐÐÕþ³¤¹Ù²úÉúÀàºúÂܲ·ËصÄÉúÎïÌå½øÐÐÁË̽ÌÖ£¬ÎªÉú²úÀàºúÂܲ·ËØ¡£ÕâÖÖÒìÖÖÉú²úÊÇÒÀÀµÓÚ¸ßЧ±í´ïϵͳ£¬ÎªÀàºúÂܲ·ËصĻùÒò´Ø£¬µ«Ôö¼ÓµÄ¹©Ó¦Á¿Ç°ÌåÔÚËÞÖ÷ÉúÎïÌ壬ÊǾßÓÐÖØÒªÒâÒåµÄ¡£¸Ã½Íĸ¾úÄîÖé¾úÓÐÓúÍÊÈcereviseaeÒѸÄÔìΪÉú²ú·¬ÇѺìËØºÍB -ºúÂܲ·ËØ£¬ÏºÇàËØ¡£¸ÃÔ­ºËÉúÎï´ó³¦¸Ë¾úÊÇ×î²ûÊöÁË×÷ΪÒìÖÖÖ÷»ú£¬ÒòΪ´ó²¿·ÖµÄ»ùÒò£¬ÒѾ­ÌåÏÖÔÚÓ¦±ä¹¦ÄÜ·ÖÎö¡£¸ÅÊöÁËÒìÖÖ±í´ïµÄÀàºúÂܲ·ËصĻùÒò´ØÔÚÈý¸öÌá¼°·ÇcarotenogenicÖ÷³ÖÈ˽éÉÜËùÉú²úµÄÀàºúÂܲ·ËØÔÚ¶«µÀ¹úÐèÒªºÏ³ÉµÄÖмäggdp ¡£´ó³¦¸Ë¾ú²úÉúc15ǰÕ×FDPµÄÄÚÔ´ÐÔÝÆÀà·Ö×Ó¡£À©½¨µÄÒìÎìÏ©Á´c20ÒѾ­Ñݳö±í´ïÁËcrte»ùÒò±àÂëgeranygeranyl diphoÐÐÕþ³¤¹ÙsphateºÏøŷÎÄsp ..Õâprenyltransferase´ß»¯Éú²úggdp´Ó¹ûÌÇ¡£¸ÃggdpºÏø±àÂë»ùÒòµÄÈ«Çò¶¨Î»ÏµÍ³ÓÉarchaeoglobus fulgidisÒ»Ö±±íÏÖΪºÃ¡£±í´ïÕâÖÖ»ùÒòÊǸüÓÐЧÂʵģ¬ÒòΪø´ß»¯µÄÈý¸öÁ´É쳤·´Ó¦£¬´Ó̼ÎåǰÕ×Ïòc20 molecule.one·½Ê½£¬ÒÔÔö¼ÓÍâÔ´Éú²ú£¬ÊÇÔö¼Ó³ØÌåÔÚ¶«µÀ¹ú¡£¹ý¶ÈµÄ¼¸¸ö»ùÒòµÄÉÏÓΣ¬ÔÚÀàÒìÎì¶þÏ©ÉúÎïºÏ³ÉµÄ½á¹ûÊÇÈ·¶¨ºÍ¿Ë·þµÄÆ¿¾±£¬ÔÚÕâ·½ÃæµÄÃÅ·¡£·²±í´ïÒ»ÖÖÀàºúÂܲ·ËصĻùÒò´ØÔÚCÓÐÓõ¼ÖÂÁË·¬ÇѺìËØµÄÉú²ú1.1ºÁ¿ËG 〜Ϊ1 £¨¸ÉÖØ£©µÄϸ°û£¬¹ý¶ÈµÄ´ß»¯ÇøµÄ±£ÊØÇøÅ©Î¯µÄø£¬²ÎÓëÀàÒìÎì¶þÏ©ÉúÎïºÏ³É¾­mevalonateͨ·£¬Ôì³É4±¶µÄÔö·ù¡£ÏÂÁÐÈÅÂÒÁËÂó½Ç¹Ì´¼µÄÉúÎïºÏ³É»ùÒòerg9±àÂëöèÏ©ºÏøµÄ²úÉú¸üÊÇ·¬ÇѺìËØ£¨ 7.8ºÁ¿ËG 〜Ϊ1 £¨¸ÉÖØ£©µÄϸ°û£© £¬ÒÔÔö¼ÓÀàÒìÎì¶þϩͨÁ¿Ôڴ󳦸˾úÖеö»ùÒòµÄdoxpͨ·Òѹý¶È¡£Õâ¾Í²úÉúÁËÒ»¸ö×î¸ßÔö¼ÓÁË10±¶£¬×ܺúÂܲ·ËØÉú²ú¬tion ¡£¹ý¶È±í´ïµÄ»ùÒò±àÂëµÄøÔÚÉúÎïºÏ³É;¾¶²¢²»×ÜÊǽâ¾ö·½°¸½Ï¸ßµÄÉú²úˮƽ£¬ÒòΪËüÃÇÍùÍùÔì³ÉÒ»ÖÖ²»Æ½ºâµÄг´úлϵͳµÄ¼ÄÖ÷ϸ°û¡£¹æÀýµÄǰÌ幩ӦºÍ±í´ïˮƽÄÜÓÐÖúÓÚÍÆ¶¯ÒìÖÖÉúÎïϵͳ£¬ÒÔ¼°»·¾³¡£¸ºÃæÓ°Ïì¹ýËٶȼ«Ï޵ĵ°°×ÖÊÒѱ»Ö¤Ã÷ΪdeoxyxyluloseÁ×ËáºÏø»ùÒò£¨ dxs £© ¡£Ê¹ÓÃÒ»ÖÖmulticopyÖÊÁ£ÔØÓн»ÚÑ»áÆô¶¯£¬Ôì³É¼õÉÙµÄÔö³¤ºÍÉú²úµÄ·¬ÇѺìËØÊ±£¬±í´ïIPTGÓÕµ¼ÏÂdxs»ùÒò½¨ÔìÒ»¸öµÍ¿½±´ÖÊÁ££¬²¢Ã»ÓÐÏÔʾÕâЩ²»ÀûÓ°Ïì¡£¶ø·ÇÖÊÁ£Ç¿ÁÒÊɾúÌåT5µÄÆô¶¯×ÓÒѱ»ÓÃÀ´È¡´ú±¾ÍÁÆô¶¯×ÓÔڴ󳦸˾úÖС£×÷Ϊһ¸öºó¹û£¬±í´ïµÄÔö¼Ó£¬ÀàÒìÎì¶þÏ©»ùÒòµ¼Ö¸ĽøÉú²ú·¬ÇѺìËØ£¨ 6ºÁ¿ËG 〜Ϊ1¸ÉÖØ£© £¬Ôڴ󳦸˾úÖС£ÕâÒ»²úÁ¿ÊÇÏàæÇÃÀµÄˮƽ£¬Ëù²úÉúµÄÀàºúÂܲ·ËØÉú²úmicroorganims ¡£ÁíÒ»ÖÖ°ì·¨£¬ÒÔ¹æ¹Ü´úлͨÁ¿¶ÔÌØ¶¨ÀàºúÂܲ·ËØÒѹ۲쵽Óý¨¹¹º¬ÓÐmRNAÎȶ¨ÐÔ¿ØÖÆÒªËØ¡£ÔÓÎï¬tionµÄmRNAÎȶ¨ÐÔµ÷ÖÆÍ¨Á¿µÄÀàºúÂܲ·ËØÉú²úµÄ300±¶£¬ÊµÏÖµÄBºúÂܲ·ËØÏà¶Ôlycopene.theÓà¶î³ö·¢Ç°ÌåµÄdoxpͨ·¾¯·½ÒÑÕ¹¿ªµ÷²é£¬ÓÉÅ©ÃñÓëÁΡ£¹ýÈ¥£¬ÄãµÄ±í´ïÊý¸öÖÐÑë´úлø»ùÒòÖØ¶¨ÏòͨÁ¿±ûͪËá¶Ô¸ÊÓÍÈýÁ×ËᣬÒò¶øÔö¼ÓÁË·¬ÇѺìËØÔÚÒìÖִ󳦸˾ú¾úÖꡣͬһ¼¯ÍÅÒ²ÊÔͼÉè¼ÆÒ»Ì׿ØÖÆÏµÍ³Öеıí´ïÏÞÖÆÃ¸·¨²½Ö裬ÓÃÈ˹¤°ûloop.since´ó¶àÊýÀàºúÂܲ·ËصĻùÒò£¬²»Í¬À´Ô´µÄ¹¦ÄÜ£¬¿ÉÒÔÒ»ÆðÔÚÒ»¸öÖ÷³ÖÈË£¬½áºÏ¶àÖÖøµÄ×éºÏ£¬µ¼ÖÂÉú²úеÄÀàºúÂܲ·ËصĽṹ²»ÊǹÂÁ¢µÄ£¬´ÓÐÔÖÊbefore.theÀûÓÃËÞÖ÷ϸ°û¸øÈ˵Ļú»á£¬ÀûÓö¨Ïò½ø»¯¼¼Êõ£¬Îª¸ÄÔì½ÍËØµÈ¡£Ê©ÃÜÌØ- dannertµÈÈË¡£Ï´ÅÆphytoeneºÏ³ÉøµÄϸ¾ú²»Í¬ÎïÖÖ£¬Õâµ¼ÖÂÁËÔÚÒ»¸öÍêÈ«¹²éîÀàºúÂܲ·Ëغ¬6¸ö¶ø²»ÊÇ4¸öË«¼ü¡£½áºÏÏ´ÅÆ·¬ÇѺìËØºÏø±íÏÖ³öÉú²úµÄµ¥»·ÀàºúÂܲ·ËØtorulene ¡£À©´óÕâЩͨ·ÓëÆäËûÀàºúÂܲ·ËØÐÞÊÎø£¬µ¼ÖÂÉú²úµÄÐÂÐͽṹÔڴ󳦸˾ú¡£¶¨Ïò½ø»¯Òѱ»ÓÃÀ´ÖÆÔìÀàºúÂܲ·ËØ·Ö×ÓÓ벻ͬÊýÄ¿µÄ̼ԭ×Ó£¨ c30 £¬ c35 £¬ c45ºÍC50ÐÍ£©×÷Ϊwell.out¸Ã¼¯ÍŵÄÝÆÀ໯ºÏÎÀàºúÂܲ·Ëر»µ÷²éµÄ´ó²¿·ÖÔÚÉú²úÓÉ×ÔÈ»·ÇÉú²ú΢ÉúÎïºÍÉú²úеĽṹ×éºÏÉúÎïºÏ³É²ßÂÔ¡£Ïà·´£¬ÒÔÉÌÒµÀûÒæ£¬ÖÆÒ©Ïà¹ØµÄÕâЩ»¯ºÏÎïËÆºõûÓÐÓèÒԸ߶ÈÖØÊÓ£¬ÔÚʱ¿Ì¡£È»¶ø£¬ÖªÊ¶³öÕâ·½ÃæµÄ¹¤×÷¿ÉÒÔÓÃÓÚÒìÖÖÉú²úÆäËûÓмÛÖµµÄÝÆÀàÒ©ÎïÒ»Ñù£¬Ìáµ½ÇàÝïËØ»ò×Ïɼ´¼¡£¾¡¹ÜÊÇͽÀ͵ģ¬ÄãÓÐÄÜÁ¦µÄÀàºúÂܲ·ËصĻùÒò´Ø¼°ÀĽ»µÄø²ÎÓëÁËÀàºúÂܲ·ËصĺϳÉÊÇûÓгöϯ£¬Îª½á¹¹µÄÆäËûÝÆÀ໯ºÏÎËùÈ¡µÃµÄ½øÕ¹£¬ÌرðÊÇÔÚ¹¤³ÌÉÏÓÎͨ·´´Ôì¸ü¸ßµÄͨÁ¿ofgeneralÀàÒìÎì¶þÏ©µÄǰÌ壬¿ÉÓÃÓÚËùÓÐÝÆÀà½á¹¹×÷Ϊ¼ÆÊýΪ¶¨Ïò½ø»¯¼¼ÊõµÈ¡£
123456789
3Â¥2008-02-13 13:41:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

kejiduwan

Í­³æ (СÓÐÃûÆø)

Â¥Éϲ»ºñµÀ »úÆ÷·­Ò룡
4Â¥2008-02-13 14:10:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ +18 ´ÌÍ´jk 2026-04-06 19/950 2026-04-07 00:02 by longlong0822
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì320Çóµ÷¼Á£¬080500 +7 »Æ¹ÏζÊíÆ¬ 2026-04-06 7/350 2026-04-06 22:38 by qlm5820
[¿¼ÑÐ] 285Çóµ÷¼Á +5 mapmath 2026-04-06 6/300 2026-04-06 17:18 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 308Çóµ÷¼Á +13 ÌÈÈôÆð·çÁËÄØ 2026-04-05 13/650 2026-04-06 14:20 by ½¯ð©Óí
[¿¼ÑÐ] 081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ +18 ÅûÐÇºÓ 2026-04-03 18/900 2026-04-06 13:55 by BruceLiu320
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÏÃÃÅ´óѧ£¬ÉúÎïÓëÒ½Ò©£¬×Ü·Ö272£¬±¾¿Æ211 +4 Electron1cc 2026-04-01 5/250 2026-04-06 10:45 by barlinike
[¿¼ÑÐ] 281Çóµ÷¼Á +8 Ò¬×ÓÄ¢¹½ 2026-04-06 8/400 2026-04-06 10:38 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 359Çóµ÷¼Á +7 hhhhaaaa$ 2026-04-04 7/350 2026-04-04 18:49 by imissbao
[¿¼ÑÐ] 22408£¬264Çóµ÷¼Á +3 ywh729 2026-04-03 4/200 2026-04-04 11:04 by ywh729
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸±±¾©ÖÐÒ½Ò©´óѧ +3 СС´ï²»Áï 2026-04-02 3/150 2026-04-03 22:55 by ³åʸêÄÐÇÍÅ
[¿¼ÑÐ] 350Ò»Ö¾Ô¸±±¾©º½¿Õº½Ìì´óѧ08500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +5 kjnasfss 2026-04-03 5/250 2026-04-03 22:29 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 085601Ò»Ö¾Ô¸±±Àí325·ÖÇóµ÷¼Á +6 ÕÒµ÷¼Á£¬£¬ 2026-04-02 6/300 2026-04-03 22:20 by –¹Æ?
[¿¼ÑÐ] »úеר˶297 +3 Afksy 2026-04-03 3/150 2026-04-03 14:24 by 1753564080
[¿¼ÑÐ] 320Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 3/150 2026-04-03 11:40 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] Çóµ÷¼Á22408 288·Ö +5 new382 2026-04-02 5/250 2026-04-03 09:13 by ×íÔÚ·çÀï
[¿¼ÑÐ] 08¿ªÍ·¿´¹ýÀ´£¡£¡£¡ +4 wwwwffffff 2026-03-31 6/300 2026-04-02 11:42 by ¾ùÖµ»Ø¹é
[¿¼ÑÐ] 0710ÉúÎïѧÇóµ÷¼Á +9 manman511 2026-04-01 9/450 2026-04-02 10:00 by zxl830724
[¿¼ÑÐ] Ò»Ö¾Ô¸346ÉϺ£´óѧÉúÎïѧ +3 ÉϺ£´óѧ346µ÷¼Á 2026-04-01 3/150 2026-04-02 08:36 by w³æ³æ123
[˶²©¼ÒÔ°] ²©Ò»±»ËͳöÁªÅà¸Ð¾õ²»ÊÊÓ¦Ôõô°ì +3 È«´åµÄ¹· 2026-03-31 3/150 2026-04-01 10:44 by 328838485
[¿¼ÑÐ] 267Çóµ÷¼Á +13 uiybh 2026-03-31 13/650 2026-04-01 10:25 by ̽123
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û